2BB score and signals
Cartesian Therapeutics, Inc.’s current 2BB score is 33 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 17 | Very Low |
| Momentum | 12 | Strongly Weakening |
| Financial strength | 17 | Very Weak |
| Quality | 80 | Very Strong |
| Risk | 55 | Moderate |
Company facts
| Headquarters | Frederick, Maryland, United States |
| Founded | 2007 |
| Employees | 75 |
| 52-week range | $5.60 – $11.80 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2026-11-04 | — | -0.9662 | — | $102,000.00 |
| 2026-08-05 | — | -0.8859 | — | $137,445.00 |
| 2026-04-30 | -1.46 | -0.901 | $78,000.00 | $101,826.00 |
| 2026-03-09 | -3.57 | -0.8704 | $947,000.00 | $96,563.00 |
Related companies
2BBBullish & Bearish